Syncom Formulation (India) (BOM:524470) Receivables Turnover : 0.69 (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Syncom Formulation (India) Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Syncom Formulation (India)'s Revenue for the three months ended in Dec. 2023 was ₹651 Mil. Syncom Formulation (India)'s average Accounts Receivable for the three months ended in Dec. 2023 was ₹939 Mil. Hence, Syncom Formulation (India)'s Receivables Turnover for the three months ended in Dec. 2023 was 0.69.

Syncom Formulation (India) Receivables Turnover Historical Data

The historical data trend for Syncom Formulation (India)'s Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syncom Formulation (India) Receivables Turnover Chart

Syncom Formulation (India) Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Receivables Turnover

Get a 7-Day Free Trial

4.61

4.73

4.05

3.06

3.11

Syncom Formulation (India) Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Receivables Turnover	Get a 7-Day Free Trial															0.76	0.78	0.79	0.68	0.69

Competitive Comparison of Syncom Formulation (India)'s Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Syncom Formulation (India)'s Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syncom Formulation (India)'s Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syncom Formulation (India)'s Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Syncom Formulation (India)'s Receivables Turnover falls into.

Syncom Formulation (India) Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Syncom Formulation (India)'s Receivables Turnover for the fiscal year that ended in Mar. 2023 is calculated as

	Receivables Turnover (A: Mar. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2023 )	/ (	(Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )
=	2224.861	/ (	(675.501	+	755.071)	/	2 )
=	2224.861	/	715.286
=	3.11

Syncom Formulation (India)'s Receivables Turnover for the quarter that ended in Dec. 2023 is calculated as

	Receivables Turnover (Q: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2023 )	/ (	(Accounts Receivable (Q: Sep. 2023 )	+	Accounts Receivable (Q: Dec. 2023 ))	/	count )
=	651.395	/ (	(939.055	+	0)	/	1 )
=	651.395	/	939.055
=	0.69

Syncom Formulation (India) (BOM:524470) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Syncom Formulation (India) Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Syncom Formulation (India)'s Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Syncom Formulation (India) (BOM:524470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syncom Formulation (India) Ltd (BOM:524470) » Definitions » Receivables Turnover

Traded in Other Exchanges

SYNCOMF:India

Address

207, Saket Nagar, Near Saket Club, Indore, MP, IND, 452018

Website

https://www.sfil.in

Syncom Formulation (India) Ltd is in the business of pharmaceuticals. The company operates through three segments including manufacturing and dealings in Pharmaceutical drugs and formulations, Trading of commodities, and Renting of property. It manufactures and markets pharmaceutical formulation products in various dosage forms like tablets, capsules, liquids orals, liquids vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and Herbals. The company's product includes generic, antiviral, antidepressant, cough suppressant, electrolyte, histamine, estrogen, and much more. It generates maximum revenue through the Pharmaceutical drugs and formulations segment.

Syncom Formulation (India) (BOM:524470) Headlines

No Headlines